AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05935410 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: DM Social Needs
Description: 6-monthly sessions of telephone delivered, manualized education and skills training on diabetes management, and problem solving and resolution of social needs.
Study NCT05935410 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: Diabetes education materials in accordance with recommendations from the American Diabetes Association (ADA) will be mailed monthly.
Study NCT05405751 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY]
Description: Patients enrolled in the study and accessing the HIV consultation will start treatment with BIKTARVY on the day of enrollment. Medication will be provided by the sponsor and dispensed through the pharmacy service. The drug will be delivered to the patient with a delegated person outside the hospital environment or it will be the patient himself who picks up the medication.
Study NCT05692232 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pressure biofeedback guided DCFM strength training
Description: A pressure biofeedback guided DCFM strength training was carried out according to the Jull protocol. Keeping the participant's cervical spine in a neutral position and ensuring a stabilizer pressure biofeedback unit placed beneath the cervical lordosis. The pressure sensor was inflated at 20mm Hg. The participants were asked to nod their heads slowly. As the DCFM is activated, the cervical lordosis gently flattens, and the pressure sensor measures an increase in pressure. The activation score is the maximum pressure that can maintain for 10 seconds.
Study NCT05692232 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Manual therapy
Description: A manual therapy, including a slow, sustained elongation of muscles with a holding period of 7-10 seconds and a superficial oscillatory mobilization (grade-I) with 1-2 oscillations per second for 30 seconds per session was performed on the DCFM and at the cervical spine (C0-C5), respectively. The participants were asked to lie supine and prone while delivering stretching and mobilization, respectively.
Study NCT06303141 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Closed Chain exercises
Description: Open eyes and closed eyes across arm (3 sets x 60 sec) Lateral step down (3 sets x 6-12 reps) Semi-Squat Exercise (3sets x 6-12 reps) Thera-band isometric (3 sets x 10 -15sec each)
Study NCT06303141 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neuromuscular Training
Description: Neuromuscular Training Exercise:~* Single Leg Raise (3 sec x 30sec each)~* Ankle eversion/inversion (3 sets x 25 reps)~* Double Hopping in place then out of place (3 sets 30 sec)~* Reach with feet (3 sets x 30-60 sec each)~* Reach with hands (3 sets x 30-60 sec each)~* Wobble board Exercise (3sets x 30-60sec each
Study NCT06303141 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mobilization with Movement
Description: Joint mobilization with movement (by Mulligan) refers to manual therapy techniques that are used to modulate pain and treat joint dysfunctions that limit the range of motion (ROM).~(3 sets x 6 oscillation/glide each)
Study NCT05339633 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: [14C]-D-0502
Description: Drug: \[14C\]-D-0502 and D-0502
Study NCT06373978 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Diclofenac
Description: 50mg every 8hours as needed for pain
Study NCT06373978 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tramadol
Description: 50mg every 8hours as needed for pain
Study NCT06373978 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Acetaminophen
Description: 1000mg every 8hours as needed for pain
Study NCT06373978 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Acetaminophen
Description: 1000mg every 8hours as needed for pain
Study NCT05377866 — intervention group
Intervention type: OTHER
Intervention: Remote proctoring using HoloLens
Description: Assess Microsoft HoloLens as an interactive communication device in remote proctoring, and enhancement of teamwork in complex CTO procedures.
Study NCT05121688 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Physiotherapy
Description: A Tele-face-to-face multimodal physical therapy program based on health education, respiratory exercises, physical training exercises, aerobic exercises and functional mobility.
Study NCT05121688 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physiotherapy
Description: A Tele-face-to-face multimodal physical therapy program based on health education, respiratory exercises, physical training exercises, aerobic exercises and functional mobility.
Study NCT04950413 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional physical therapy program
Description: Infrared, Exercises, Stretching exercise of Suboccepital muscle
Study NCT04950413 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional physical therapy program
Description: Infrared, Exercises, Stretching exercise of Suboccepital muscle
Study NCT04950413 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: IASTM by M2t blade
Description: A lubricant (Vaseline) will be applied to the skin around the neck area prior to treatment and the M2t blade will be cleaned with an alcohol pad. First, the M2T blade will used to ﬁnd the exact areas of restriction in affected muscles. Then the M2T blade will use at an angle of 45 to apply slow strokes along the muscle. Changes in soft tissue consistency will detected by the clinician through vibrations of the instrument when it slides on areas of irregular fibrosis of the underneath connective tissue. Once an adhesion is discovered, strokes are repeated for 5 min.
Study NCT04950413 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Phonophoresis
Description: It will be consisted of 1 MHz pulsed mode with an intensity set at 1.5 W/cm2 and. A 5 cm2 crystal head with an effective radiating area of 4.0 cm2 ±1.0 wills utilized for 5 Min for each trigger point of neck. lidocine gelwill applied instead of coupling US gel used for transmission.
Study NCT05491551 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Treatment-Regulation of Craving
Description: Participants will be trained in using the MBT-based mindfulness strategy as described above (notice craving and accept the feeling without judgment or reaction). Participants will then be instructed to think of accepting and non-reactive responses when they see the instruction ACCEPT during ROC-T. On each trial, participants will receive an instruction and then be exposed to a novel alcohol image for 6 seconds. On 25% of the trials, they will see the LOOK instruction, and be allowed to experience craving (as baseline). On 75% of the trials, participants will see ACCEPT and then practice thinking about the negative consequences of drinking. After the picture disappears, they will rate their craving on every trial using a 1-5 Likert scale.
Study NCT05491551 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive-Based Therapy-Regulation of Craving
Description: Participants will be trained in using the CBT strategy by first considering and reading about the negative consequences of drinking. Participants will then be instructed to think of those negative consequences (Focus on the negative consequences associated with drinking) when they see the instruction REFRAME during ROC-T.On each trial, participants will receive an instruction and then be exposed to a novel alcohol image for 6 seconds. On 25% of the trials, they will see the LOOK instruction, and be allowed to experience craving (as baseline). On 75% of the trials, participants will see REFRAME and then practice thinking about the negative consequences of drinking. After the picture disappears, they will rate their craving on every trial using a 1-5 Likert scale
Study NCT05052879 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Toronto association
Description: Toronto association coated tablet, 20 mg + 30 mg or 20 mg + 60 mg, oral, 2 hours before the sexual intercourse.
Study NCT05052879 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tadalafil
Description: Tadalafil coated tablet, 20 mg, oral, 2 hours before the sexual intercourse.
Study NCT05052879 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tadalafil placebo
Description: Tadalafil placebo coated tablet, oral, 2 hours before the sexual intercourse.
Study NCT05052879 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Toronto association placebo
Description: Toronto association placebo coated tablet, oral, 2 hours before the sexual intercourse.
Study NCT06498817 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard Recommendation
Description: Standard recommendation given by government of Bangladesh on the use of oral rehydration solution (ORS) and a flyer on water treatment and handwashing with soap given at the health facility during the time of diarrhea patient treatment.
Study NCT06498817 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Recommendation
Description: Standard recommendation given by government of Bangladesh on the use of oral rehydration solution (ORS) and a flyer on water treatment and handwashing with soap given at the health facility during the time of diarrhea patient treatment.
Study NCT06498817 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CHoBI7 Scale-Up Program
Description: Health promoter delivery of handwashing with soap, water treatment, and safe water storage module in the health facility to diarrhea patients and the patient's household members during the time of treatment. This module includes video testimonials from diarrhea patient households on how the patient benefits from adhering to the promoted behaviors, and a demonstration on how to construct homemade handwashing washing stations. This in-person module is reinforced by weekly voice, interactive voice response, and text messages for three months sent to the mobile phones of diarrhea patient household members from a doctor at diarrhea ward at local hospital.
Study NCT06568445 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Maintenance at initial treatment sequential as-needed therapy with inhaled budesonide-formoterol(Symbicort 160/4.5) ®）
Description: one inhalation twice daily for 4 weeks maintenance, sequential as-needed for symptom relief (no more than 8 inhalations per day) to 24-week.
Study NCT06568445 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: as-needed therapy with inhaled budesonide-formoterol (Symbicort 160/4.5) ®）
Description: as-needed for symptom relief (no more than 8 inhalations per day) to 24-week.
Study NCT04461080 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Community Health Worker
Description: Trained Community Health Worker
Study NCT04461080 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Community Health Worker
Description: Trained Community Health Worker
Study NCT04832555 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Non elective radiotherapy
Description: Simultaneous integrated boost on CTV volumes, delineated as per guidelines, with the exception of intermediate-low risk, where the CTVs are experimental.
Study NCT06576830 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methadone
Description: Single-dose intraoperative intravenous methadone with initial dose at 0.15 mg/kg in children and 0.2 mg/kg in adolescents.
Study NCT06576830 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fentanyl/Hydromorphone
Description: Per routine care, given as needed
Study NCT06103864 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dato-DXd
Description: Provided in 100mg vials. IV infusion. Experimental drug.
Study NCT06103864 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: Provided in 500mg vials. IV infusion. Experimental drug.
Study NCT04243824 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gallium 68 Macro-aggregated albumin
Description: The radiotracer, Ga-68 MAA, will be administered prior to PET/MRI scan.
Study NCT06103864 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paclitaxel
Description: IV infusion. Active comparator.
Study NCT06103864 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nab-paclitaxel
Description: IV infusion. Active comparator.
Study NCT04986618 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: One-way Nordic Exercise
Description: Participants in this group will be given the standard Nordic Hamstring exercise.
Study NCT04986618 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Two-way Nordic Exercise
Description: In addition to the standard Nordic Hamstring exercise, participants in this group will do the same exercise backwards for the quadriceps.
Study NCT06103864 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gemcitabine
Description: IV infusion. Active comparator.
Study NCT06103864 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: IV infusion. Active comparator.
Study NCT06103864 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pembrolizumab
Description: IV infusion. Active comparator.
Study NCT06362304 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: 99mTc-CNDG SPECT/CT
Description: FDG-PET and 99mTc-CNDG will be performed within 2 weeks before surgery.
Study NCT05351216 — intervention group
Intervention type: OTHER
Description: No intervention
Study NCT06262490 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Traditional ultrasound therapy
Description: Ultrasound therapy for 2 session per week for until completing 12 treatment sessions (six weeks) with frequencies up to 3 MHz are used clinically to promote healing
Study NCT06262490 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Traditional ultrasound therapy
Description: Ultrasound therapy for 2 session per week for until completing 12 treatment sessions (six weeks) with frequencies up to 3 MHz are used clinically to promote healing
Study NCT06262490 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pelvic floor rehabilitation
Description: Pelvic floor rehabilitation for 3 sessions per week for (six weeks) until completing 18 sessions with sessions lasting between 30-45 minutes
Study NCT04308759 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental Smoking Cessation Program
Description: Participate in Quitbot experimental cessation program
Study NCT04308759 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Smoking Cessation Program
Description: Participate in Quitbot control cessation program
Study NCT05188287 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HealthyCells
Description: Smoking cessation smartphone app
Study NCT04967989 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Low Energy SLT
Description: SLT performed at low energy
Study NCT04967989 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Low Energy SLT
Description: SLT performed at low energy
Study NCT04967989 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard Energy SLT
Description: SLT performed at standard energy
Study NCT05012098 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bintrafusp alfa / M7824
Description: Participants will be treated with bintrafusp alfa 1200 mg every 2 weeks for 26 doses.
Study NCT05855473 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Auricular acupuncture
Description: The NADA protocol used in this study uses five specific points on the ear: Shen men, sympathetic autonomic, lung, liver, and kidney. Using this protocol, semi-permanent needles and seeds were placed unilaterally at five specific points in the ear by a specialist physician certified in acupuncture.
Study NCT04309760 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: MRI
Description: Subjects will receive structural and functional (resting state) MRI
Study NCT04309760 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: MRI
Description: Subjects will receive structural and functional (resting state) MRI
Study NCT05314413 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Single Leg Immobilization
Description: 7-days of single leg immobilization to induce muscle atrophy
Study NCT06330545 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation therapy
Description: Patients with Dupuytren's Contacture will undergo Collagenase Clostridium Histolyticum injection and release followed by two 5-day courses of radiation therapy separated by 6-8 weeks. They will then be followed for 3 years for recurrence.
Study NCT05692232 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional intervention
Description: A hot pads was applied for 20minutes underneath the cervical spine covering either side of shoulder in a relaxed supine position.
Study NCT05692232 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional intervention
Description: A hot pads was applied for 20minutes underneath the cervical spine covering either side of shoulder in a relaxed supine position.
Study NCT05447559 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Cefazolin
Description: Intravenous administration of 2 g cefazolin
Study NCT05447559 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cefazolin
Description: Intravenous administration of 2 g cefazolin
Study NCT05447559 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Water for injection
Description: Intravenous administration of 10mL sterile water for injection
Study NCT05176327 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Exoskeleton training with Ekso NR
Description: Walking exercise with Ekso NR
Study NCT05176327 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Exoskeleton training with Ekso NR
Description: Walking exercise with Ekso NR
Study NCT05447559 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Water for injection
Description: Intravenous administration of 10mL sterile water for injection
Study NCT06318091 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: platelet poor plasma gel
Description: injection of platelet poor plasma gel in the dark circles around the eye to rejuvenate and improve pigmentation
Study NCT06318091 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: nanofat
Description: injection of nanofat in the dark circles around the eye to rejuvenate and improve pigmentation
Study NCT05508321 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Nasal brushing
Description: Nasal brushing to harvest nasal cells and perform staining experiments
Study NCT05508321 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Nasal brushing
Description: Nasal brushing to harvest nasal cells and perform staining experiments
Study NCT05508321 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Sniffin' Sticks
Description: Assessment of olfactory function
Study NCT05508321 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Sniffin' Sticks
Description: Assessment of olfactory function
Study NCT05234099 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: 18F-FDG Positron emission tomography - MRI
Description: All the examinations will be performed in the supine position on the same integrated 3T PET-MRI scanner
Study NCT05234099 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Multiparametric ultrasound imaging
Description: Acquisitions of respiratory muscles (diaphragm, intercostal muscles) will be performed using two 6 MHz central frequency linear transducer (SL 10-2) driven by two identical ultrafast ultrasound devices.
Study NCT05234099 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Surface electromyography
Description: sEMG recordings will be performed in the left side on the sternocleidomastoid muscle, the intercostal parasternal muscle, and the external oblique muscle using pairs of 20-mm-diameter silver chloride surface electrodes.
Study NCT05234099 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Transdiaphragmatic preasure measurmement
Description: Esophageal and gastric pressures will be measured using 8-cm balloon-catheters.
Study NCT05234099 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Magnetic stimulation of the phrenic nerves
Description: In order to quantify the contractile fatigue in diaphragm induced by the ventilatory task (described below), we will use bilateral anterior magnetic stimulation of the phrenic nerves using two Magstim 200 stimulator.
Study NCT05234099 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Ventilation against inspiratory loading
Description: A POWERbreathe KH2 device (POWERbreathe International Ltd) will be connected on the inspiratory side of the two-way valve. Level of inspiratory loading will be randomized in order to produce different amounts of muscle work in each subject.
Study NCT05465044 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Twice-weekly hemodialysis with incremental crossover to thrice-weekly schedule
Description: 50% of the eligible participants will be assigned to twice-weekly hemodialysis for up to 12 months with incremental crossover to thrice-weekly hemodialysis as indicated.